IRIS Accounts Production v25.2.0.378 08773965 director 1.12.23 30.11.24 30.11.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh087739652023-11-30087739652024-11-30087739652023-12-012024-11-30087739652022-11-30087739652022-12-012023-11-30087739652023-11-3008773965ns15:EnglandWales2023-12-012024-11-3008773965ns14:PoundSterling2023-12-012024-11-3008773965ns10:Director12023-12-012024-11-3008773965ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3008773965ns10:SmallEntities2023-12-012024-11-3008773965ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-3008773965ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3008773965ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3008773965ns10:FullAccounts2023-12-012024-11-3008773965ns10:RegisteredOffice2023-12-012024-11-3008773965ns5:CurrentFinancialInstruments2024-11-3008773965ns5:CurrentFinancialInstruments2023-11-3008773965ns5:Non-currentFinancialInstruments2024-11-3008773965ns5:Non-currentFinancialInstruments2023-11-3008773965ns5:ShareCapital2024-11-3008773965ns5:ShareCapital2023-11-3008773965ns5:RetainedEarningsAccumulatedLosses2024-11-3008773965ns5:RetainedEarningsAccumulatedLosses2023-11-3008773965ns5:PlantMachinery2023-12-012024-11-3008773965ns5:LandBuildings2023-11-3008773965ns5:LeaseholdImprovements2023-11-3008773965ns5:PlantMachinery2023-11-3008773965ns5:LandBuildings2023-12-012024-11-3008773965ns5:LeaseholdImprovements2023-12-012024-11-3008773965ns5:LandBuildings2024-11-3008773965ns5:LeaseholdImprovements2024-11-3008773965ns5:PlantMachinery2024-11-3008773965ns5:LandBuildings2023-11-3008773965ns5:LeaseholdImprovements2023-11-3008773965ns5:PlantMachinery2023-11-3008773965ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3008773965ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-3008773965ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-11-3008773965ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-11-3008773965ns5:RetainedEarningsAccumulatedLosses2023-11-3008773965ns5:RetainedEarningsAccumulatedLosses2023-12-012024-11-30
REGISTERED NUMBER: 08773965 (England and Wales)










Financial Statements

for the Year Ended 30 November 2024

for

Million Medical Ltd

Million Medical Ltd (Registered number: 08773965)






Contents of the Financial Statements
for the Year Ended 30 November 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Million Medical Ltd

Company Information
for the Year Ended 30 November 2024







DIRECTOR: Ms M P E Mok





REGISTERED OFFICE: 187 Hylton Road
Sunderland
SR4 7YE





REGISTERED NUMBER: 08773965 (England and Wales)





ACCOUNTANTS: SKS Bailey Group Limited
52-56 Coatsworth Road
Gateshead
NE8 1QN

Million Medical Ltd (Registered number: 08773965)

Balance Sheet
30 November 2024

2024 2023
Notes £    £   
Fixed assets
Tangible assets 3 349,912 335,997

Current assets
Stocks 122,880 81,832
Debtors 4 2,184,132 1,287,633
Cash at bank 1,914 69,452
2,308,926 1,438,917
Creditors
Amounts falling due within one year 5 (975,898 ) (1,018,416 )
Net current assets 1,333,028 420,501
Total assets less current liabilities 1,682,940 756,498

Creditors
Amounts falling due after more than one
year

6

(928,865

)

-
Net assets 754,075 756,498

Capital and reserves
Called up share capital 99 99
Retained earnings 8 753,976 756,399
754,075 756,498

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Million Medical Ltd (Registered number: 08773965)

Balance Sheet - continued
30 November 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 26 September 2025 and were signed by:





Ms M P E Mok - Director


Million Medical Ltd (Registered number: 08773965)

Notes to the Financial Statements
for the Year Ended 30 November 2024

1. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 15% on reducing balance

STOCKS
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

TAXATION
Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 15 (2023 - 7 ) .

Million Medical Ltd (Registered number: 08773965)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

3. TANGIBLE FIXED ASSETS
Improvements
Freehold to Plant and
property property machinery Totals
£    £    £    £   
COST
At 1 December 2023 343,336 15,600 59,013 417,949
Additions - 23,983 - 23,983
At 30 November 2024 343,336 39,583 59,013 441,932
DEPRECIATION
At 1 December 2023 50,477 2,340 29,135 81,952
Charge for year - 5,586 4,482 10,068
At 30 November 2024 50,477 7,926 33,617 92,020
NET BOOK VALUE
At 30 November 2024 292,859 31,657 25,396 349,912
At 30 November 2023 292,859 13,260 29,878 335,997

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 474,291 522,447
Inter company loan 1,659,353 653,359
Other debtors VAT refundable 50,488 111,827
2,184,132 1,287,633

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts (see note 7) 68,357 -
Other loans (see note 7) 284,655 391,775
Trade creditors 433,734 402,760
Pension 1,170 1,040
Corporation tax 33,719 49,575
Social security and other tax 11,351 4,367
Other creditors 31,022 31,022
Directors' current accounts 111,890 137,877
975,898 1,018,416

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans (see note 7) 928,865 -

Million Medical Ltd (Registered number: 08773965)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

7. LOANS

An analysis of the maturity of loans is given below:

2024 2023
£    £   
Amounts falling due within one year or on demand:
Bank overdrafts 28,343 -
Bank loans 40,014 -
Other loans 284,655 391,775
353,012 391,775

Amounts falling due between two and five years:
Bank loans - 2-5 years 296,621 -
Bank loan more than 5 year 632,244 -
928,865 -

8. RESERVES
Retained
earnings
£   

At 1 December 2023 756,399
Profit for the year 27,577
Dividends (30,000 )
At 30 November 2024 753,976